Parliamentary questions

404. Deputy Peadar Tóibín asked the Minister for Health whether she is aware of any instances where unvetted IT staff were granted access to sensitive clinical environments, including ICU, operating theatres or other restricted areas; and, if so, the risk assessments or investigations that were carried out. [22826/26]

405. Deputy Peadar Tóibín asked the Minister for Health the policies, controls, and verification procedures in place within CHI and the HSE to ensure that all staff, including contractors, are appropriately Garda vetted prior to being granted access to clinical areas. [22827/26]

406. Deputy Peadar Tóibín asked the Minister for Health whether she has engaged directly with the CHI Chief Information Officer in relation to issues concerning NIMIS; and if so, to provide details of such engagements and any actions arising. [22829/26]

407. Deputy Peadar Tóibín asked the Minister for Health whether she is aware of protected disclosures made by staff within CHI in relation to IT systems, governance, or patient safety concerns; if so, the actions that were taken; the investigations that were carried out; and the outcomes or remedial measures that were implemented. [22830/26]

408. Deputy Peadar Tóibín asked the Minister for Health whether she has engaged with any whistleblowers or representatives in relation to concerns raised within CHI; and if so, to provide details. [22831/26]

409. Deputy Peadar Tóibín asked the Minister for Health whether any communications have taken place between her and senior CHI leadership, including the CEO, in relation to protected disclosures made by staff; and if so, to provide details. [22832/26]

410. Deputy Peadar Tóibín asked the Minister for Health the protections, supports, and remedies that are currently in place for healthcare staff who make protected disclosures within CHI and the HSE, including psychological supports, employment protections, and access to compensation or redress where harm has occurred. [22833/26]

411. Deputy Peadar Tóibín asked the Minister for Health whether she is aware of concerns regarding workplace culture, including allegations of bullying or high staff turnover within IT functions in CHI; and whether any review or investigation have been conducted. [22834/26]

412. Deputy Peadar Tóibín asked the Minister for Health whether any assessment has been carried out into the impact of staffing instability or turnover on system reliability, governance, and patient safety, particularly in relation to critical systems such as NIMIS. [22835/26]

413. Deputy Barry Ward asked the Minister for Health if her attention has been drawn to calls to allow for the provision of veoza (fezolinetant) under the drug payment scheme; and if she will make a statement on the matter. [22853/26]

414. Deputy Barry Ward asked the Minister for Health the research carried out by her Department into the benefits of the use of veoza (fezolinetant) in the treatment of cancer patients; and if she will make a statement on the matter. [22854/26]

415. Deputy Barry Ward asked the Minister for Health the position regarding any engagement she has had with the HSE in relation to the proposal to allow for the provision of veoza (fezolinetant) under the drug payment scheme; and if she will make a statement on the matter. [22855/26]

416. Deputy Barry Ward asked the Minister for Health the position regarding any engagement she has had with an organisation (details supplied) or any other health group in relation to the proposal to allow for the provision of veoza (fezolinetant) under the drug payment scheme; and if she will make a statement on the matter. [22856/26]

417. Deputy Barry Ward asked the Minister for Health the position regarding the number of employees that were employed in her Department at the end of December 2025, broken down by grade, in tabular form; and if she will make a statement on the matter. [22876/26]

418. Deputy Barry Ward asked the Minister for Health the number of employees in each of the agencies under her Department's remit at the end of December 2025, broken down by grade, in tabular form; and if she will make a statement on the matter. [22898/26]

419. Deputy Aengus Ó Snodaigh asked the Minister for Health whether the National Dementia Strategy will be updated; the status of the National Dementia Strategy in relation to the Model of Care for Dementia; whether a full-term review is intended to be published following the 2018 Mid-Term Review; whether the National Dementia Strategy Monitoring Group are presently active; and if she will make a …

420. Deputy Pádraig Rice asked the Minister for Health to respond to matters raised in correspondence (details supplied); if her attention has been drawn to the discrepancies around the cost of a medical report; and if she will make a statement on the matter. [22937/26]

421. Deputy Pádraig Rice asked the Minister for Health further to Parliamentary Question No. 1858 of 18 March 2026, if a cohort of infants can receive a second RSV immunisation in winter 2026-2027 (details supplied); and if she will make a statement on the matter. [22952/26]

422. Deputy Pádraig Rice asked the Minister for Health the reason for the prolonged delay in commencing section 232 of the Health (Assisted Human Reproduction) Act 2024; the timeline for signing the concurrence and the commencement order; and if she will make a statement on the matter. [22953/26]

423. Deputy Pádraig Rice asked the Minister for Health if her attention has been drawn to a discrepancy between published agreed eligibility criteria and campaign criteria for a role within the National Ambulance Service (details supplied); if this application process will be reviewed given that a number of eligible staff were deemed ineligible; and if she will make a statement on the matter. [229…

424. Deputy Marie Sherlock asked the Minister for Health the clinical pathways in the health system for treating myalgic encephalomyelitis. [22956/26]

425. Deputy Marie Sherlock asked the Minister for Health the hospitals that currently provide care to those with severe and very severe myalgic encephalomyelitis; and the names of the consultant doctors. [22957/26]

426. Deputy Marie Sherlock asked the Minister for Health if she is satisfied that sufficient care and treatment is available to sufferers of severe and very severe myalgic encephalomyelitis in the public health system. [22958/26]

427. Deputy Marie Sherlock asked the Minister for Health the arrangements, if any, the HSE has entered into with clinics or hospitals abroad for the care of patients with myalgic encephalomyelitis. [22959/26]

428. Deputy Marie Sherlock asked the Minister for Health the number of sufferers of severe or very severe myalgic encephalomyelitis that are currently in public nursing homes and are under 65 years-of-age [22960/26]